HI homepage

Trending
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval
Does BMI affect AI's accuracy when assessing CT scans?
New GE HealthCare partnership expands access to prostate cancer imaging agent
Repetitive head impact in soccer players increases risk of brain damage, MRI shows
Expert panel develops new breast biopsy guidelines
Howard Berger, MD, RadNet chairman and CEO, discusses why the company has invested millions into DeepHealth to rapidly build up a new business model for artificial intelligence capabilities in radiology. #RSNA #HealthAI #ClinicalAI #Radiology
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Congress Senate Washington D.C. DC
Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

With eight Democrats agreeing to the Republican-backed deal that reverses the firings of federal workers, the Senate now has the 60 votes needed for the bill to advance. The rehirings will include the 1,200 workers fired at the Department of Health and Human Services. 

lung cancer screening
Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.
More applications, fewer interviews—how preference signaling has impacted rad resident placements

A new analysis suggests that preference signaling can both help and hinder residents’ efforts during the application process.

A CTA scan being performed at Beaumont Hospital in Michigan by cardiac CT expert Kavitha M Chinnaiyan, MD. CCTA has largely been used at academic medical centers for the past decade, but it is now expanding in 2022 to community hospitals and clinics thanks to a Class 1A recommendation in the 2021 chest pain guidelines. #CCTA #CTA #Beaumont
CCTA outperforms TEE after LAAO, new meta-analysis confirms

Researchers reviewed data from more than 1,300 patients who underwent both CCTA and TEE after undergoing LAAO. The two modalities were comparable in many ways, but cardiac CT was linked to a few key benefits.

scanner money radiology dollar MRI CT payment compensation
When it comes to image-guided ablations, the most cost-effective modality is also the least effective option

Ablation therapy used to treat hepatocellular carcinoma requires image guidance, which is usually done via ultrasound, CT or MRI.

stroke brain dementia alzheimer's puzzle mental health
MRI findings may signal patients' receptiveness to different mental health treatment methods

Differences in connectivity patterns could reveal which patients are most likely to respond positively to self-guided therapy.

translate language
GPT-4o translates radiology reports written in different languages in less than 30 seconds

These findings could have positive implications for regions with diverse patient populations, authors of a new analysis suggest.
Radiology cyberattack exposes data from hundreds of thousands of patients in Washington

The incident happened in January of this year, with attackers gaining access to the practice’s systems for five days before they were shut out. 

Around the web

Radiology Business
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Cardiovascular Business
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Radiology Business
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.